Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125622671 | 12562267 | 1 | I | 201504 | 20160701 | 20160715 | 20160715 | EXP | CA-HQ SPECIALTY-CA-2016INT000532 | INTERCHEM | 54.00 | YR | F | Y | 0.00000 | 20160714 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125622671 | 12562267 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | 3.5714 (25 MG,1 IN 1 W) | 201749 | 25 | MG | |||||||||
| 125622671 | 12562267 | 2 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | 2 G,1 D | 0 | 2 | G | |||||||||
| 125622671 | 12562267 | 3 | SS | ARAVA | LEFLUNOMIDE | 1 | 20 MG, 1 D | 0 | 20 | MG | |||||||||
| 125622671 | 12562267 | 4 | SS | MOXIFLOXACIN. | MOXIFLOXACIN | 1 | UNK | U | 0 | ||||||||||
| 125622671 | 12562267 | 5 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 125622671 | 12562267 | 6 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | 400 MG, 1 D | 0 | 400 | MG | |||||||||
| 125622671 | 12562267 | 7 | C | CELEBREX | CELECOXIB | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125622671 | 12562267 | 1 | Rheumatoid arthritis |
| 125622671 | 12562267 | 2 | Rheumatoid arthritis |
| 125622671 | 12562267 | 3 | Rheumatoid arthritis |
| 125622671 | 12562267 | 4 | Product used for unknown indication |
| 125622671 | 12562267 | 5 | Rheumatoid arthritis |
| 125622671 | 12562267 | 6 | Product used for unknown indication |
| 125622671 | 12562267 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125622671 | 12562267 | HO |
| 125622671 | 12562267 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125622671 | 12562267 | Drug hypersensitivity | |
| 125622671 | 12562267 | Pneumonia | |
| 125622671 | 12562267 | Toxicity to various agents | |
| 125622671 | 12562267 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125622671 | 12562267 | 1 | 20140709 | 20150501 | 0 | |
| 125622671 | 12562267 | 2 | 20150817 | 20150830 | 0 | |
| 125622671 | 12562267 | 3 | 20141201 | 20150505 | 0 | |
| 125622671 | 12562267 | 5 | 201408 | 0 | ||
| 125622671 | 12562267 | 6 | 20150817 | 0 | ||
| 125622671 | 12562267 | 7 | 20160520 | 0 |